Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)
7.915
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Shanghai Pharmaceuticals Shareholders Equity (Quarterly): 9.845B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.845B |
December 31, 2023 | 9.667B |
September 30, 2023 | 9.390B |
June 30, 2023 | 9.286B |
June 30, 2023 | 9.286B |
March 31, 2023 | 9.963B |
December 31, 2022 | 9.720B |
September 30, 2022 | 9.286B |
June 30, 2022 | 9.748B |
June 30, 2022 | 9.748B |
March 31, 2022 | 10.15B |
December 31, 2021 | 7.744B |
September 30, 2021 | 7.519B |
June 30, 2021 | 7.381B |
June 30, 2021 | 7.381B |
March 31, 2021 | 7.206B |
December 31, 2020 | 6.942B |
September 30, 2020 | 6.499B |
June 30, 2020 | 6.053B |
June 30, 2020 | 6.053B |
March 31, 2020 | 5.994B |
December 31, 2019 | 5.954B |
September 30, 2019 | 5.745B |
June 30, 2019 | 5.820B |
June 30, 2019 | 5.820B |
Date | Value |
---|---|
March 31, 2019 | 5.974B |
December 31, 2018 | 5.671B |
September 30, 2018 | 5.605B |
June 30, 2018 | 5.641B |
June 30, 2018 | 5.641B |
March 31, 2018 | 5.971B |
December 31, 2017 | 5.213B |
September 30, 2017 | 4.999B |
June 30, 2017 | 4.796B |
June 30, 2017 | 4.796B |
March 31, 2017 | 4.742B |
December 31, 2016 | 4.553B |
September 30, 2016 | 4.729B |
June 30, 2016 | 4.643B |
June 30, 2016 | 4.643B |
March 31, 2016 | 4.773B |
December 31, 2015 | 4.610B |
September 30, 2015 | 4.573B |
June 30, 2015 | 4.587B |
June 30, 2015 | 4.587B |
March 31, 2015 | 4.601B |
December 31, 2014 | 4.485B |
September 30, 2014 | 4.407B |
June 30, 2014 | 4.270B |
June 30, 2014 | 4.270B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.745B
Minimum
Sep 2019
10.15B
Maximum
Mar 2022
7.928B
Average
7.519B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.709B |
CASI Pharmaceuticals Inc | 24.16M |
Zai Lab Ltd | 762.17M |
Gracell Biotechnologies Inc (DELISTED) | 222.18M |
Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 30.55B |
Total Liabilities (Quarterly) | 19.02B |
Debt to Equity Ratio | 0.6794 |
Current Ratio | 1.336 |
Net Debt Paydown Yield | -4.78% |